Biktarvy – HIV Treatment & Viral Suppression

Biktarvy is a once-daily prescription medication used for the treatment of HIV-1 infection in adults. It combines bictegravir, emtricitabine, and tenofovir alafenamide for effective viral suppression. This powerful HIV treatment helps reduce viral load and supports long-term immune health. With consistent use under medical guidance, Biktarvy improves quality of life and helps patients maintain control over their condition. It offers convenience, effectiveness, and reliable HIV management.

What is Biktarvy?

Biktarvy is a prescription HIV treatment combining bictegravir, emtricitabine, and tenofovir alafenamide in one daily tablet. It effectively suppresses HIV-1, reducing viral load and helping patients maintain a healthier immune system. By preventing the virus from multiplying, Biktarvy supports long-term immune health and lowers the risk of HIV-related complications. Consistent use under medical supervision helps patients achieve viral suppression, improve quality of life, and manage HIV effectively.

Benefits of Biktarvy

• Once-daily pill: Simplifies HIV treatment with a single tablet.
• Reduces viral load: Helps achieve undetectable levels of HIV.
• Minimal side effects: Well-tolerated compared to older HIV treatments.
• Long-term management: Effective for both treatment-naive and experienced patients.

Biktarvy should be taken daily and monitored regularly to ensure continued viral suppression.

Recommended for both treatment-naive and experienced patients.

It provides reliable HIV care for patients starting treatment as well as those with prior therapy experience.

This medication supports both newly diagnosed individuals and patients who have undergone previous HIV